New pill aims to help people with diabetes shed pounds and control blood sugar

NCT ID NCT07400588

Ongoing Disease control Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new daily pill, aleniglipron, in 58 adults with type 2 diabetes who are overweight or obese. The main goal is to check if the drug is safe and tolerable at different doses. Researchers will also measure weight loss and blood sugar changes. The study is not yet recruiting and is in Phase 2.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESE OBESITY OBESITY TYPE 2 DIABETES MELLITUS WEIGHT LOSS

Contacts and locations

Locations

Research Site

Anniston, Alabama, 36207, United States
Research Site

Lake Forest, California, 92630, United States
Research Site

Lomita, California, 90717, United States
Research Site

Hazelwood, Missouri, 63042, United States
Research Site

Columbus, Ohio, 43212, United States
Research Site

Moncks Corner, South Carolina, 29461, United States
Research Site

Chattanooga, Tennessee, 37421, United States
Research Site

Knoxville, Tennessee, 37909, United States
Research Site

Austin, Texas, 78704, United States
Research Site

DeSoto, Texas, 75115, United States
Research Site

Houston, Texas, 77079, United States
Research Site

Mesquite, Texas, 75149, United States
Research Site

San Antonio, Texas, 78215, United States
Research Site

San Antonio, Texas, 78229, United States
Research Site

San Antonio, Texas, 78240, United States
Research Site

Tomball, Texas, 77375, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.